Literature DB >> 20074551

ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling.

Hayley K Charlton1, Julie Webster, Sarah Kruger, Fiona Simpson, Ayanthi A Richards, Jonathan P Whitehead.   

Abstract

The pleiotropic effects of the insulin-sensitizing adipokine adiponectin are mediated, at least in part, by two seven-transmembrane domain receptors AdipoR1 and AdipoR2. Recent reports indicate a role for AdipoR-binding proteins, namely APPL1, RACK1 and CK2beta, in proximal signal transduction events. Here we demonstrate that endoplasmic reticulum protein 46 (ERp46) interacts specifically with AdipoR1 and provide evidence that ERp46 modulates adiponectin signalling. Co-immunoprecipitation followed by mass spectrometry identified ERp46 as an AdipoR1-, but not AdipoR2-, interacting protein. Analysis of truncated constructs and GST-fusion proteins revealed the interaction was mediated by the cytoplasmic, N-terminal residues (1-70) of AdipoR1. Indirect immunofluorescence microscopy and subcellular fractionation studies demonstrated that ERp46 was present in the ER and the plasma membrane (PM). Transient knockdown of ERp46 increased the levels of AdipoR1, and AdipoR2, at the PM and this correlated with increased adiponectin-stimulated phosphorylation of AMPK. In contrast, adiponectin-stimulated phosphorylation of p38MAPK was reduced following ERp46 knockdown. Collectively these results establish ERp46 as the first AdipoR1-specific interacting protein and suggest a role for ERp46 in adiponectin receptor biology and adiponectin signalling. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074551     DOI: 10.1016/j.bbrc.2010.01.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Adiponectin receptor 1 interacts with both subunits of protein kinase CK2.

Authors:  Cathleen Juhl; Karin Mörl; Annette G Beck-Sickinger
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes.

Authors:  Liming Yu; Qisheng Tu; Qianqian Han; Lan Zhang; Lei Sui; Leilei Zheng; Shu Meng; Yin Tang; Dongying Xuan; Jin Zhang; Dana Murray; Qingping Shen; Jessica Cheng; Sung-Hoon Kim; Lily Q Dong; Paloma Valverde; Xinming Cao; Jake Chen
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

Review 3.  Adiponectin receptor signalling in the brain.

Authors:  John Thundyil; Dale Pavlovski; Christopher G Sobey; Thiruma V Arumugam
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 4.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Molecular characterization of the endoplasmic reticulum: insights from proteomic studies.

Authors:  Xuequn Chen; Alla Karnovsky; Maria Dolors Sans; Philip C Andrews; John A Williams
Journal:  Proteomics       Date:  2010-11-02       Impact factor: 3.984

6.  The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.

Authors:  L Wang; G Song; X Chang; W Tan; J Pan; X Zhu; Z Liu; M Qi; J Yu; B Han
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

7.  Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins.

Authors:  Markus Neumeier; Sabrina Krautbauer; Sandra Schmidhofer; Yvonne Hader; Kristina Eisinger; Elke Eggenhofer; Stanley C Froehner; Marvin E Adams; Wolfgang Mages; Christa Buechler
Journal:  Exp Mol Pathol       Date:  2013-07-13       Impact factor: 3.362

8.  High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.

Authors:  Ren Mo; Jingtao Peng; Jiantao Xiao; Jian Ma; Weiguo Li; Jing Wang; Yuan Ruan; Shaofei Ma; Yan Hong; Chenji Wang; Kun Gao; Jie Fan
Journal:  Tumour Biol       Date:  2016-01-26

9.  Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis.

Authors:  Xiaotian Chang; Yan Zhao; Xinfeng Yan; Jihong Pan; Kehua Fang; Lin Wang
Journal:  Arthritis Res Ther       Date:  2011-07-29       Impact factor: 5.156

10.  Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.

Authors:  Lin Wang; Yabing Zheng; Hengwei Xu; Xinfeng Yan; Xiaotian Chang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.